Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
509 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Show Display Options
Rank Status Study
21 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
22 Not yet recruiting Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention: Drug: ticagrelor
23 Not yet recruiting Vorapaxar and Lower Extremity Bypass Grafts
Condition: Peripheral Artery Disease
Interventions: Drug: Vorapaxar;   Drug: Placebos
24 Recruiting Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy
Condition: Hypertriglyceridemia
Interventions: Drug: Vascepa;   Drug: placebo
25 Recruiting Vorapaxar in the Human Endotoxemia Model
Condition: Healthy Volunteers
Interventions: Drug: Vorapaxar;   Drug: Placebo;   Other: LPS
26 Not yet recruiting Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
Conditions: Portal Hypertension;   Liver Cirrhosis
Interventions: Drug: Ifetroban;   Drug: Placebo
27 Not yet recruiting Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults
Condition: Alzheimer's Disease
Interventions: Drug: icosapent ethyl (IPE);   Other: gel cap placebo
28 Recruiting Effect of W-3 Polyunsaturated Fatty Acids on Serum Albumin Concentration in Patients With Acute Heart Failure, Hypoalbuminemia, and High Inflammatory Activity
Condition: Heart Failure
Interventions: Drug: Polyunsaturated fatty acids omega-3;   Drug: Placebo
29 Recruiting Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Conditions: Scleroderma, Diffuse;   Scleroderma, Systemic;   Scleroderma, Limited;   Sclerosis, Progressive Systemic;   Skin Diseases;   Connective Tissue Diseases;   Pathologic Processes;   Autoimmune Diseases
Interventions: Drug: Oral Ifetroban;   Drug: Oral Placebo
30 Not yet recruiting Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access
Condition: Fistula
Interventions: Drug: Vorapaxar sulfate;   Drug: Placebo
31 Recruiting Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects
Conditions: Type 2 Diabetes;   Coronary Artery Disease
Intervention: Drug: Icosapent ethyl
32 Recruiting Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints
Condition: HIV
Interventions: Drug: vorapaxar;   Drug: Placebo
33 Recruiting Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Condition: Coronary Artery Bypass
Interventions: Drug: Prasugrel;   Drug: Placebo
34 Recruiting Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Conditions: Myocardial Infarction;   Acute Coronary Syndromes;   Unstable Angina
Interventions: Drug: Short Tirofiban;   Drug: Eptifibatide;   Drug: Long Tirofiban
35 Recruiting Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
Condition: Unsuspected Pulmonary Embolism
Intervention: Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
36 Not yet recruiting Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
Conditions: Coronary Artery Disease;   Myocardial Ischemia;   Myocardial Infarction;   Stent Thrombosis;   Cardiovascular Diseases
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
37 Recruiting Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI
Condition: Acute Coronary Syndrome
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
38 Recruiting Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
39 Recruiting Effect of Iloprost on Pulmonary Oxygenation in Patients With Low Diffusing Capacity During One-lung Ventilation
Condition: Lung Cancer
Interventions: Drug: iloprost;   Drug: normal saline
40 Recruiting Iloprost in Preventing Lung Cancer in Former Smokers
Conditions: Lung Carcinoma;   Mild Dysplasia;   Precancerous Condition
Interventions: Drug: Iloprost;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.